Compile Data Set for Download or QSAR
Report error Found 10 Enz. Inhib. hit(s) with all data for entry = 6491
LigandPNGBDBM132093(US8841288, CL27e)
Affinity DataIC50: 20nMT: 2°CAssay Description:Some compounds of formula (I) described herein were assayed in vitro for their ability to inhibit the lipid kinase activity of PI3Ks, by using a non-...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM132092(US8841288, CL12)
Affinity DataIC50: 100nMT: 2°CAssay Description:Some compounds of formula (I) described herein were assayed in vitro for their ability to inhibit the lipid kinase activity of PI3Ks, by using a non-...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM132095(US8841288, CL55a)
Affinity DataIC50: 100nMT: 2°CAssay Description:Some compounds of formula (I) described herein were assayed in vitro for their ability to inhibit the lipid kinase activity of PI3Ks, by using a non-...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM132096(US8841288, CL55b)
Affinity DataIC50: 100nMT: 2°CAssay Description:Some compounds of formula (I) described herein were assayed in vitro for their ability to inhibit the lipid kinase activity of PI3Ks, by using a non-...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM132097(US8841288, CL 64a)
Affinity DataIC50: 100nMT: 2°CAssay Description:Some compounds of formula (I) described herein were assayed in vitro for their ability to inhibit the lipid kinase activity of PI3Ks, by using a non-...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM132098(US8841288, CL 129A)
Affinity DataIC50: 140nMT: 2°CAssay Description:Some compounds of formula (I) described herein were assayed in vitro for their ability to inhibit the lipid kinase activity of PI3Ks, by using a non-...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM132089(US8841288, TP714)
Affinity DataIC50: 260nMT: 2°CAssay Description:Some compounds of formula (I) described herein were assayed in vitro for their ability to inhibit the lipid kinase activity of PI3Ks, by using a non-...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM132091(US8841288, CL5)
Affinity DataIC50: 260nMT: 2°CAssay Description:Some compounds of formula (I) described herein were assayed in vitro for their ability to inhibit the lipid kinase activity of PI3Ks, by using a non-...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM132094(US8841288, CL29a)
Affinity DataIC50: 320nMT: 2°CAssay Description:Some compounds of formula (I) described herein were assayed in vitro for their ability to inhibit the lipid kinase activity of PI3Ks, by using a non-...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM132090(US8841288, CL1)
Affinity DataIC50: 730nMT: 2°CAssay Description:Some compounds of formula (I) described herein were assayed in vitro for their ability to inhibit the lipid kinase activity of PI3Ks, by using a non-...More data for this Ligand-Target Pair
In DepthDetails
US Patent